{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:39Z","timestamp":1786991319415,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006544","name":"Ministry of Health, State of Israel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaip.2019.07.034","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:43:32Z","timestamp":1564746212000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Risk Factors and Treatment Outcomes for Oral Immunotherapy\u2013Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER)"],"prefix":"10.1016","volume":"8","author":[{"given":"Michael R.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Nachshon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Elizur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitzhak","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.07.034_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.anai.2013.10.001","article-title":"Clinical predictors for favorable outcomes in an oral immunotherapy program for IgE-mediated cow\u2019s milk allergy","volume":"112","author":"Levy","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2013.05.006","article-title":"Long-term follow-up of oral immunotherapy for cow\u2019s milk allergy","volume":"132","author":"Keet","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.aller.2011.05.004","article-title":"Adverse effects during specific oral tolerance induction: in home phase","volume":"40","author":"Barbi","year":"2012","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2019.07.034_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2016.07.030","article-title":"Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy","volume":"139","author":"Virkud","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/all.12794","article-title":"Clinical and laboratory 2-year outcome of oral immunotherapy in patients with cow\u2019s milk allergy","volume":"71","author":"Elizur","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.07.034_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gtc.2014.02.012","article-title":"Eosinophilic esophagitis: clinical presentation in children","volume":"43","author":"Liacouras","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaip.2019.07.034_bib7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.anai.2014.08.004","article-title":"Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis","volume":"113","author":"Lucendo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.anai.2017.11.016","article-title":"Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy","volume":"120","author":"Petroni","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.09.053","article-title":"Oral immunotherapy-induced gastrointestinal symptoms and peripheral blood eosinophil responses","volume":"139","author":"Goldberg","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of eosinophilic esophagitis","volume":"154","author":"O\u2019Shea","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2019.07.034_bib11","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/j.gastro.2012.03.001","article-title":"Elimination diet effectively treats eosinophilic esophagitis in adults: food reintroduction identifies causative factors","volume":"142","author":"Gonsalves","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2019.07.034_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.aller.2016.05.002","article-title":"Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy","volume":"44","author":"Echeverr\u00eda-Zudaire","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2019.07.034_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaip.2018.05.023","article-title":"Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients","volume":"7","author":"Wasserman","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.07.034_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.anai.2015.04.007","article-title":"A\u00a0website-based reporting system for monitoring home treatment during oral immunotherapy for food allergy","volume":"114","author":"Nachshon","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jaci.2014.05.042","article-title":"Oral immunotherapy induces IgG antibodies that act through Fc\u03b3RIIb to suppress IgE-mediated hypersensitivity","volume":"134","author":"Burton","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.07.034_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S2352-4642(19)30029-X","article-title":"Walnut oral immunotherapy for desensitisation of walnut and additional tree nut allergies (Nut CRACKER): a single-centre, prospective cohort study","volume":"3","author":"Elizur","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaip.2019.07.034_bib18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm.3281","article-title":"Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis","volume":"19","author":"Noti","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2019.07.034_bib19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","article-title":"Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis","volume":"146","author":"Arias","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2019.07.034_bib20","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jaci.2017.05.034","article-title":"Association study of childhood food allergy with genome-wide association studies-discovered loci of atopic dermatitis and eosinophilic esophagitis","volume":"140","author":"Hirota","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ppul.23327","article-title":"Increased prevalence of airway reactivity in children with eosinophilic esophagitis","volume":"51","author":"Krupp","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaip.2019.07.034_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaip.2016.11.020","article-title":"The prevalence of eosinophilic esophagitis in pediatric patients with IgE mediated food allergy","volume":"5","author":"Hill","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.07.034_bib23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/17474124.2014.909727","article-title":"Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications","volume":"8","author":"Lucendo","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2019.07.034_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaci.2018.02.049","article-title":"Specific IgG4 antibodies to cow\u2019s milk proteins in pediatric patients with eosinophilic esophagitis","volume":"142","author":"Schuyler","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib25","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3389\/fimmu.2018.02624","article-title":"Baseline gastrointestinal eosinophilia is common in oral immunotherapy subjects with IgE-mediated peanut allergy","volume":"9","author":"Wright","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaip.2017.04.037","article-title":"Eosinophilic esophagitis: latent disease in patients with anaphylactic reaction to cow\u2019s milk","volume":"6","author":"Barbosa","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.07.034_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2019.07.034_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pai.12914","article-title":"Long-term outcome of peanut oral immunotherapy\u2014real-life experience","volume":"29","author":"Nachshon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.07.034_bib29","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N\u00a0Engl J Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930652X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930652X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:20:20Z","timestamp":1761974420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321981930652X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S221321981930652X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.07.034","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors and Treatment Outcomes for Oral Immunotherapy\u2013Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}